Your Catalyst To a Lucrative Business
Table of Content of Pharmacovigilance Market
Chapter 1. Executive Summary 1.1. Pharmacovigilance- Industry Summary and Critical Success Factors( CSFs)
Chapter 2. Pharmacovigilance Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Pharmacovigilance- Market dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Pharmacovigilance- PESTEL Analysis 2.6. Pharmacovigilance Company Market Share Analysis, 2013
Chapter 3. Pharmacovigilance Clinical Trial Phase Outlook 3.1. Pharmacovigilance market share, by clinical trial phase, 2013 & 2020 3.2. Preclinical
3.2.1. Preclinical Market Estimates and Forecasts, 2012- 2020( USD Million) 3.3. Phase 0
3.3.1. Phase 0 Market Estimates and Forecasts, 2012- 2020( USD Million) 3.4. Phase I
3.4.1. Phase I Market Estimates and Forecasts, 2012- 2020( USD Million) 3.5. Phase II
3.5.1. Phase II Market Estimates and Forecasts, 2012- 2020( USD Million) 3.6. Phase III
3.6.1. Phase III Market Estimates and Forecasts, 2012- 2020( USD Million) 3.7. Phase IV
3.7.1. Phase IV Market Estimates and Forecasts, 2012- 2020( USD Million)
Chapter 4. Pharmacovigilance Type of Service Provider Outlook 4.1. Pharmacovigilance market share, by type of service provider, 2013 & 2020 4.2. In- House
4.2.1. In-House Market Estimates and Forecasts, 2012- 2020( USD Million) 4.3. Contract Outsourcing
4.3.1. Contract Outsourcing Market Estimates and Forecasts, 2012- 2020( USD Million)
Follow Us: